บุคลากรสายวิชาการ

ผศ.ดร.ภญ. ศิตาพร ยังคง ผศ.ดร.ภญ. ศิตาพร ยังคง sitaporn.you@mahidol.ac.th sitaporn.you@mahidol.ac.th อาจารย์ประจำภาควิชาเภสัชกรรม

2021

1. A systematic review of demand-side methods of estimating the societal monetary value of health gain

   Gloria MAJ, Thavorncharoensap M*, Chaikledkaew U, Youngkong S, Thakkinstian A, Culyer AJ. Value in Health 2021; 24(10): 1423-1434.
   
   

2. Cost-utility analysis of dapagliflozin compared to sulfonylureas for type 2 diabetes as second-line treatment in indian healthcare payer’s perspective

   Bagepally BS, Chaikledkaew U*, Youngkong S, Anothaisintawee T, Thavorncharoensap M, Dejthevaporn C, Thakkinstian A. ClinicoEconomics and Outcomes Research 2021; 13: 897-907.
   
   

3. Economic analysis for national immunization program planning: A case of rotavirus vaccines in Burundi

   Niyibitegeka F, Riewpaiboon A*, Youngkong S, Thavorncharoensap M. Vaccine 2021; 39(8) :1272-1282.
   
   

4. Economic burden of childhood diarrhea in Burundi

   Niyibitegeka F, Riewpaiboon A*, Youngkong S, Thavorncharoensap M. Global Health Research and Policy 2021; 6(1): 13.
   
   

5. Knowledge, attitude and practice of traditional medicine-related adverse drug reaction (adr) reporting among hospital pharmacists and traditional medicine practitioners in Thailand

   Worakunphanich W, Thongsombutpanitch F, Nilsonthi S, Youngkong S, Thavorncharoensap M*. Pharmaceutical Sciences Asia 2021; 48(4): 330-338.
   
   

6. Safety of andrographis paniculata: A systematic review and meta-analysis

   Worakunphanich W, Thavorncharoensap M*, Youngkong S, Thadanipon K, Thakkinstian A. Pharmacoepidemiology and Drug Safety 2021; 30(6): 727-739.
   
   

2020

1. Cost-effectiveness and resource allocation (CERA) 18 years of evolution: Maturity of adulthood and promise beyond tomorrow

   Jakovljevic M*, Matter-Walstra K, Sugahara T, Sharma T, Reshetnikov V, Merrick J, Yamada T, Youngkong S, Rovira J. Cost effectiveness and resource allocation 2020; 18(1): 15.
   
   

2. Glucagon-like peptide 1 agonists for treatment of patients with type 2 diabetes who fail metformin monotherapy: Systematic review and meta-analysis of economic evaluation studies

   Bagepally BS, Chaikledkaew U*, Gurav YK, Anothaisintawee T, Youngkong S, Chaiyakunapruk N, McEvoy M, Attia J, Thakkinstian A. BMJ open diabetes res care 2020; 8(1): e001020.
   
   

2019

1. Cost-effectiveness modelling studies of all preventive measures against rabies: A systematic review

   Anothaisintawee T, Julienne Genuino A, Thavorncharoensap M, Youngkong S, Rattanavipapong W, Meeyai A, Chaikledkaew U*. Vaccine 2019; 37: A146-A153.
   
   

2. Systematic review and meta-analysis of cost-effectiveness of rotavirus vaccine in low-income and lower-middle-income countries

   Haider S, Chaikledkaew U*, Thavorncharoensap M, Youngkong S, Islam MA, Thakkinstian A . Open Forum Infectious Diseases 2019; 6(4); ofz117.
   
   

3. The impact of transmission dynamics of rabies control: Systematic review

   Rattanavipapong W, Thavorncharoensap M, Youngkong S, Genuino AJ, Anothaisintawee T, Chaikledkaew U, Meeyai A*. Vaccine 2019; A154-A165.
   
   

4. Treatment cost and costing model of obstetric complications at a hospital in Myanmar

   Thi Win Shwe A, Riewpaiboon A*, Chaikledkaew U, Youngkong S. PLoS ONE 2019;14(3):e0213141
   
   

2018

1. Budgeting for a billion: applying health technology assessment (HTA) for universal health coverage in India

   Dabak S.V, Pilasant S, Mehndiratta A, Downey L.E, Cluzeau F, Chalkidou K, Gonzales Luz A.C, Youngkong S, Teerawattananon Y. Health Research Policy and Systems 2018; 16: 115
   
   

2. Incorporating MCDA into HTA: Challenges and potential solutions, with a focus on lower income settings

   Marsh K., Thokala P., Youngkong S., Chalkidou K. Cost Effectiveness and Resource Allocation 2018; 16
   
   

2016

1. Development of a Health Screening Package under the Universal Health Coverage: The Role of Health Technology Assessment

   Teerawattananon Y, Kingkaew P, Koopitakkajorn T, Youngkong S*, Tritasavit N, Srisuwan P, Tantivess S. Health Economics 2016; 25: 162-178.
   
   

2008

1. A cost function analysis of shigellosis in Thailand.

   Riewpaiboon A, Youngkong S, Sreshthaputra N, Stewart JF, Samosornsuk S, Chaicumpa W, von Seidlein L, Clemens JD Value Health 2008;11 (Suppl 1) Mar: S75-S83.
   
   

2004

1. Unit costs of medical services at Prasart Neurological Institute

   Youngkong S, Riewpaiboon A, Towanabut S, Riewpaiboon W Srinakharinwirot J Pharm Sci 2004; 9(1): 52-8
   
   

2002

1. Cost of cerebral infarction in societal perspective

   Youngkong S, Riewpaiboon A, Towanabut S, Riewpaiboon W. Srinakharinwirot J Pharm Sci 2002; 7(1): 95-105
   
   

---

หมายเหตุ: ชื่อที่ใช้ในการทำวิจัยของ ผศ.ดร.ภญ. ศิตาพร ยังคง ได้แก่ Youngkong S ;